Skip to main content
Premium Trial:

Request an Annual Quote

Nils Hoem, Martin Maduas, Francis Lunger, and Philip Petraglia

Premium

MDS Pharma has appointed Nils Hoem as director of pharmacokinetics/pharmacodynamics in Europe, the company said last week.

Hoem will be responsible for managing a team of approximately 15 scientists located in MDS’ European clinical pharmacology units. Prior to joining MDS, Hoem ran his own business, Hoem Pharma Consulting. He was also employed by Smerud Medical Research Group and the University of Oslo. He holds a PhD in clinical pharmacokinetics and pharmacodynamics from the University of Oslo.


Millipore announced last week that its new president and CEO, Martin Maduas, will start on Jan. 1, 2005. He will also join Millipore’s board of directors at that time. Maduas is assuming the roles of president and CEO from Francis Lunger, who will remain as chairman of the board until March 1, 2005, Millipore said.


Philip Petraglia has become controller of the Pittsburgh Life Sciences Greenhouse, PLSG said last week. He joins the public/private biotech investment partnership from Resources Connection, a professional services firm. Petraglia holds a bachelor’s degree from Westminster College in New Wilmington, Pa.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.